Prevalence of psilocybin use in vaping and associated factors: a study among amphetamine-type stimulants (ATS) use disorder in Malaysia

Mamat, Ruzmayuddin and Abd Rashid, Rusdi and Shin, Sim Maw and Ibrahim, Baharuddin and Wahab, Suzaily and Ahmad, Azmir (2024) Prevalence of psilocybin use in vaping and associated factors: a study among amphetamine-type stimulants (ATS) use disorder in Malaysia. Journal of Addictive Diseases, 42 (4). pp. 360-372. ISSN 1055-0887, DOI https://doi.org/10.1080/10550887.2023.2240932.

Full text not available from this repository.
Official URL: https://doi.org/10.1080/10550887.2023.2240932

Abstract

BackgroundThe emergence of New Psychoactive Substances (NPS), including synthetic psilocybin, has raised concern among health experts due to the numerous health and socioeconomic consequences. The current trend is shifting to the hazardous use of synthetic psilocybin in vaping, and little is known about the prevalence of use, specifically among amphetamine-type stimulants (ATS) users.MethodsInterviewer-administered questionnaires were conducted in drug detention centers between March and October 2022. The study was conducted using ASSIST 3.0 and obtained information on the respondents' socio-demographic characteristics and clinical profiles. N = 355 ATS users were enrolled in this study.ResultsThe results show a high prevalence of psilocybin vaping among ATS users (182/355, 53.1%). Most of the respondents were males (85.1%) and unmarried (69.3%), with a mean age of 29.2 (SD = 7.3). Across all respondents, five factors were associated with psilocybin vaping: tobacco smoking, aOR =5.790 (95% CI: 1.723, 8.183); cannabis uses, aOR= 9.152 (95% CI: 2.693, 10.396); and alcohol use, aOR= 3.137 (95% CI: 1.461, 5.817). Respondents of the Malay race had higher odds of being involved in psilocybin vaping compared to other races, with aOR= 1.638 (0.043, 2.459). Meanwhile, a reduction in age by 1.9 will increase the likelihood of involvement in psilocybin vaping with aOR = 1.897 (95% CI: 0.857, 1.938).ConclusionPsilocybin in vaping is growing among ATS users and across all populations. Unfortunately, knowledge regarding the long-term effects on health is limited. Further studies should highlight the harmful effects of psilocybin and the potential risk of psilocybin vaping among the younger population.

Item Type: Article
Funders: Ministry of Higher Education Malaysia Long-term Research Grant Scheme (LRGS/1/2019/UKM/02/2/2)
Uncontrolled Keywords: Amphetamine-type Stimulant; ATS; Psilocybin; NPS; detention centers; harm reduction; >
Subjects: R Medicine > RM Therapeutics. Pharmacology
R Medicine > RS Pharmacy and materia medica
Divisions: Faculty of Pharmacy
Faculty of Pharmacy > Department of Clinical Pharmacy and Pharmacy Practice
Depositing User: Ms. Juhaida Abd Rahim
Date Deposited: 16 Jan 2025 03:58
Last Modified: 16 Jan 2025 03:58
URI: http://eprints.um.edu.my/id/eprint/47675

Actions (login required)

View Item View Item